Methotrexate pharmacogenomics
- PMID: 16905578
- PMCID: PMC1798295
- DOI: 10.1136/ard.2006.051789
Methotrexate pharmacogenomics
Abstract
Observations of clinical effects of methotrexate will help in patient‐management decisions
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.Ann Rheum Dis. 2006 Sep;65(9):1213-8. doi: 10.1136/ard.2005.046797. Epub 2006 Jan 26. Ann Rheum Dis. 2006. PMID: 16439441 Free PMC article.
References
-
- Kremer J M. Toward a better understanding of methotrexate [review]. Arthritis Rheum 2004501370–1382. - PubMed
-
- Hughes L B, Beasley M T, Patel H, Tiwari H K, Morgan S L, Baggott J E.et al Racial/ethnic differences in allele frequencies of single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 2006 - PMC - PubMed
-
- Kim R J, Becker R C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta‐analysis of published studies. Am Heart J 2003146948–957. - PubMed
-
- Gos M, Jr, Szpecht‐potocka A. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism. J Appl Genet 200243511–524. - PubMed
-
- Schwahn B, Rozen R. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics 2001189–201. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
